PURPOSE: To examine the consequences of administration of norepinephrine on muscle tissue oxygenation in severely hypotensive septic shock patients. METHODS: This was a prospective observational study conducted in a medical intensive care unit of a university hospital. We included 28 septic shock patients that received early volume resuscitation. All were eligible for receiving norepinephrine because of life-threatening hypotension and low diastolic arterial pressure. Muscle tissue oxygen saturation (StO₂) and its changes during a vascular occlusion test were measured at the level of the thenar eminence using a near-infrared spectroscopy (NIRS) device. Transpulmonary thermodilution cardiac index (CI) and NIRS-derived variables were obtained before and after the mean arterial pressure (MAP) was increased by norepinephrine. The baseline StO₂ and the vascular occlusion test-derived variables of 17 healthy volunteers were measured and served as controls. RESULTS: In healthy volunteers, StO₂ ranged between 75 and 90% and StO₂ recovery slopes ranged between 1.5 and 3.4%/s. Administration of norepinephrine, which was associated with an increase in MAP from 54 ± 8 to 77 ± 9 mmHg (p < 0.05), also induced increases in CI from 3.14 ± 1.03 to 3.61 ± 1.28 L/min/m² (p < 0.05), in StO₂ from 75 ± 9 to 78 ± 9% (p < 0.05) and in StO₂ recovery slope from 1.0 ± 0.6 to 1.5 ± 0.7%/s (p < 0.05). CONCLUSIONS: Norepinephrine administration aimed at achieving a MAP higher than 65 mmHg in septic shock patients with life-threatening hypotension resulted in improvement of NIRS variables measured at the level of the thenar eminence.
PURPOSE: To examine the consequences of administration of norepinephrine on muscle tissue oxygenation in severely hypotensive septic shockpatients. METHODS: This was a prospective observational study conducted in a medical intensive care unit of a university hospital. We included 28 septic shockpatients that received early volume resuscitation. All were eligible for receiving norepinephrine because of life-threatening hypotension and low diastolic arterial pressure. Muscle tissue oxygen saturation (StO₂) and its changes during a vascular occlusion test were measured at the level of the thenar eminence using a near-infrared spectroscopy (NIRS) device. Transpulmonary thermodilution cardiac index (CI) and NIRS-derived variables were obtained before and after the mean arterial pressure (MAP) was increased by norepinephrine. The baseline StO₂ and the vascular occlusion test-derived variables of 17 healthy volunteers were measured and served as controls. RESULTS: In healthy volunteers, StO₂ ranged between 75 and 90% and StO₂ recovery slopes ranged between 1.5 and 3.4%/s. Administration of norepinephrine, which was associated with an increase in MAP from 54 ± 8 to 77 ± 9 mmHg (p < 0.05), also induced increases in CI from 3.14 ± 1.03 to 3.61 ± 1.28 L/min/m² (p < 0.05), in StO₂ from 75 ± 9 to 78 ± 9% (p < 0.05) and in StO₂ recovery slope from 1.0 ± 0.6 to 1.5 ± 0.7%/s (p < 0.05). CONCLUSIONS:Norepinephrine administration aimed at achieving a MAP higher than 65 mmHg in septic shockpatients with life-threatening hypotension resulted in improvement of NIRS variables measured at the level of the thenar eminence.
Authors: Christopher G Ellis; Ryon M Bateman; Michael D Sharpe; William J Sibbald; Ravi Gill Journal: Am J Physiol Heart Circ Physiol Date: 2002-01 Impact factor: 4.733
Authors: Jaume Mesquida; Jordi Masip; Gisela Gili; Antoni Artigas; Francisco Baigorri Journal: Intensive Care Med Date: 2009-01-29 Impact factor: 17.440
Authors: Yasser Sakr; Marc-Jacques Dubois; Daniel De Backer; Jacques Creteur; Jean-Louis Vincent Journal: Crit Care Med Date: 2004-09 Impact factor: 7.598
Authors: Stephen Trzeciak; Ismail Cinel; R Phillip Dellinger; Nathan I Shapiro; Ryan C Arnold; Joseph E Parrillo; Steven M Hollenberg Journal: Acad Emerg Med Date: 2008-05 Impact factor: 3.451
Authors: J Mesquida; C Espinal; G Gruartmoner; J Masip; C Sabatier; F Baigorri; M R Pinsky; A Artigas Journal: Intensive Care Med Date: 2012-02-07 Impact factor: 17.440
Authors: Djillali Annane; Lamia Ouanes-Besbes; Daniel de Backer; Bin DU; Anthony C Gordon; Glenn Hernández; Keith M Olsen; Tiffany M Osborn; Sandra Peake; James A Russell; Sergio Zanotti Cavazzoni Journal: Intensive Care Med Date: 2018-06-04 Impact factor: 17.440
Authors: Martin Balik; Jan Rulisek; Pavel Leden; Michal Zakharchenko; Michal Otahal; Hana Bartakova; Josef Korinek Journal: Wien Klin Wochenschr Date: 2012-07-20 Impact factor: 1.704